Posted: Thurs., Nov. 19, 1998

S&P upgrades Time rating to triple B

Stock soars to $98.87 on news

NEW YORK -- Time Warner achieved a long-sought objective Wednesday when Standard & Poor's upgraded its credit rating to triple B, what TW calls a "solid investment grade" rating.

News of the upgrade sent Time Warner stock soaring, closing up $1.18 to $98.87 although it traded as high as $99.68 during the day.

The upgrade reflects the company's "strong operating performance and financial discipline that have fueled improvement in key credit measures," S&P said. The agency noted that after a period of "acquisition activity and higher financial risk during the 1993-95 period," the company has instituted a more disciplined financial management in the past two years, keeping capital expenditures flat throughout the company in an effort to reduce debt and "emphasize returns on assets."

One of TW's objectives was to improve its credit rating to at least the triple B level, which helps reduce the company's borrowing costs. While its debt level has only dropped slightly, to $16 billion on Sept. 30, its cash flow (earnings before interest, taxes, depreciation and amortization) has risen sharply, lowering its debt-to-cash-flow ratio from 6.6 in '92 to 3.2 now.


TALKBACK:

Have an opinion about this article? Be the first to comment




Q What are the top 3 things affecting our industry today?
A. Benisha - scams big time!!!! and i can truly say that i have experienced this becoming apart of a fa... more >


Submit this form
Tressa, one of the many stars of A&E's 'Intervention,' talks about her lengthy battle with methamphetamine. ; reality show; intervention; A&E; emmy contenders; drug addicts; variety; Interviews with Erick McCormack, Daniel Dae Kim & Christa Miller, stars of A&E's new sci-fi thriller, 'The Andromeda Strain.'; Erick McCormack; A&E; tv; sci-fi; The Andromeda Strain; variety; Daniel Dae Kim & Christa Miller;


© 2008 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved. Use of this website is subject to its Terms & Conditions of Use. View our Privacy Policy.